| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5DX9U76296 |
| InChI Key | YCOYDOIWSSHVCK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H15ClN4 |
| Molecular Weight | 346.82 |
| AlogP | 5.01 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 50.7 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 25.0 |
| Primary Target | |
|---|---|
| kinase insert domain receptor |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Colonic Neoplasms | 3 | D003110 | ClinicalTrials |
| Rectal Neoplasms | 3 | D012004 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Multiple Myeloma | 2 | D009101 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 2 | D016403 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| von Hippel-Lindau Disease | 2 | D006623 | ClinicalTrials |
| Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
| Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Macular Degeneration | 1 | D008268 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | D015464 | ClinicalTrials |
| Kidney Neoplasms | 1 | D007680 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Uterine Cervical Neoplasms | 1 | D002583 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 212141-54-3 |
| ChEBI | 90620 |
| ChEMBL | CHEMBL101253 |
| DrugBank | DB04879 |
| EPA CompTox | DTXSID2046919 |
| FDA SRS | 5DX9U76296 |
| Guide to Pharmacology | 5705 |
| PubChem | 151194 |
| SureChEMBL | SCHEMBL18286 |
| ZINC | ZINC000000007460 |